Comments
Loading...

GoodRx Holdings Analyst Ratings

GDRXNASDAQ
Logo brought to you by Benzinga Data
$3.74
-0.08-2.09%
At close: -
$3.74
0.000.00%
After Hours: 5:13 PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$16.00
Lowest Price Target1
$4.50
Consensus Price Target1
$8.02

GoodRx Holdings Analyst Ratings and Price Targets | NASDAQ:GDRX | Benzinga

GoodRx Holdings Inc has a consensus price target of $8.02 based on the ratings of 27 analysts. The high is $16 issued by TD Cowen on May 16, 2024. The low is $4.5 issued by B of A Securities on January 2, 2024. The 3 most-recent analyst ratings were released by UBS, Goldman Sachs, and Wells Fargo on May 13, 2025, May 9, 2025, and April 29, 2025, respectively. With an average price target of $5.75 between UBS, Goldman Sachs, and Wells Fargo, there's an implied 53.74% upside for GoodRx Holdings Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
2
Jan
1
Feb
1
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS
Goldman Sachs
Wells Fargo
Truist Securities
Citigroup

1calculated from analyst ratings

Analyst Ratings for GoodRx Holdings

Buy NowGet Alert
05/13/2025Buy Now40.37%UBS
Kevin Caliendo71%
$6 → $5.25MaintainsNeutralGet Alert
05/09/2025Buy Now33.69%Goldman Sachs
Eric Sheridan79%
$6 → $5MaintainsNeutralGet Alert
04/29/2025Buy Now87.17%Wells Fargo
Stan Berenshteyn40%
$8 → $7MaintainsOverweightGet Alert
04/10/2025Buy Now47.06%Truist Securities
Jailendra Singh36%
$6.5 → $5.5MaintainsHoldGet Alert
02/28/2025Buy Now113.9%Wells Fargo
Stan Berenshteyn40%
$9 → $8MaintainsOverweightGet Alert
01/10/2025Buy Now67.11%Citigroup
Daniel Grosslight39%
$7 → $6.25MaintainsBuyGet Alert
01/08/2025Buy Now60.43%Keybanc
Scott Schoenhaus45%
$7 → $6MaintainsOverweightGet Alert
12/17/2024Buy Now60.43%Morgan Stanley
Craig Hettenbach59%
$7 → $6MaintainsEqual-WeightGet Alert
11/13/2024Buy Now87.17%Citigroup
Daniel Grosslight39%
$10 → $7MaintainsBuyGet Alert
11/11/2024Buy Now60.43%Barclays
Stephanie Davis41%
$10 → $6MaintainsOverweightGet Alert
08/16/2024Buy Now167.38%RBC Capital
Sean Dodge46%
$10 → $10ReiteratesOutperform → OutperformGet Alert
08/09/2024Buy Now127.27%UBS
Kevin Caliendo71%
$9 → $8.5MaintainsNeutralGet Alert
08/09/2024Buy Now167.38%Citigroup
Daniel Grosslight39%
$11 → $10MaintainsBuyGet Alert
06/10/2024Buy Now154.01%Morgan Stanley
Craig Hettenbach59%
$7 → $9.5MaintainsEqual-WeightGet Alert
05/23/2024Buy Now167.38%RBC Capital
Mark Mahaney82%
$8 → $10UpgradeSector Perform → OutperformGet Alert
05/20/2024Buy Now167.38%Barclays
Stephanie Davis41%
$9 → $10MaintainsOverweightGet Alert
05/16/2024Buy Now167.38%Raymond James
John Ransom76%
→ $10UpgradeMarket Perform → OutperformGet Alert
05/16/2024Buy Now327.81%TD Cowen
Charles Rhyee36%
$14 → $16MaintainsBuyGet Alert
04/10/2024Buy Now140.64%Keybanc
Scott Schoenhaus45%
→ $9UpgradeSector Weight → OverweightGet Alert
03/25/2024Buy Now167.38%Wells Fargo
Stan Berenshteyn40%
→ $10UpgradeEqual-Weight → OverweightGet Alert
03/08/2024Buy Now113.9%RBC Capital
Sean Dodge46%
$8 → $8ReiteratesSector Perform → Sector PerformGet Alert
03/01/2024Buy Now113.9%UBS
Kevin Caliendo71%
$5 → $8MaintainsNeutralGet Alert
03/01/2024Buy Now100.53%Wells Fargo
Stan Berenshteyn40%
$6 → $7.5MaintainsEqual-WeightGet Alert
03/01/2024Buy Now113.9%RBC Capital
Sean Dodge46%
$7 → $8MaintainsSector PerformGet Alert
03/01/2024Buy Now100.53%Goldman Sachs
Eric Sheridan79%
$6.5 → $7.5MaintainsNeutralGet Alert
03/01/2024Buy Now113.9%Truist Securities
Jailendra Singh36%
$7.5 → $8MaintainsHoldGet Alert
03/01/2024Buy Now274.33%TD Cowen
Charles Rhyee36%
$12 → $14MaintainsOutperformGet Alert
03/01/2024Buy Now167.38%JP Morgan
Lisa Gill56%
$7 → $10UpgradeNeutral → OverweightGet Alert
03/01/2024Buy Now140.64%Barclays
Steve Valiquette53%
$8 → $9MaintainsOverweightGet Alert
02/26/2024Buy Now113.9%Leerink Partners
Michael Cherny78%
→ $8Initiates → OutperformGet Alert
01/16/2024Buy Now87.17%RBC Capital
Sean Dodge46%
$5 → $7MaintainsSector PerformGet Alert
01/12/2024Buy Now100.53%Truist Securities
Jailendra Singh36%
$5.5 → $7.5MaintainsHoldGet Alert
01/02/2024Buy Now20.32%B of A Securities
Michael Cherny78%
$8 → $4.5DowngradeBuy → UnderperformGet Alert
11/17/2023Buy Now60.43%JP Morgan
Doug Anmuth86%
$7 → $6MaintainsNeutralGet Alert
11/13/2023Buy Now60.43%Goldman Sachs
Eric Sheridan79%
$7 → $6MaintainsNeutralGet Alert
11/10/2023Buy Now33.69%RBC Capital
Sean Dodge46%
$8 → $5MaintainsSector PerformGet Alert
11/10/2023Buy Now60.43%Goldman Sachs
Eric Sheridan79%
$7 → $6MaintainsNeutralGet Alert
11/10/2023Buy Now47.06%Truist Securities
Jailendra Singh36%
$8 → $5.5MaintainsHoldGet Alert
11/10/2023Buy Now47.06%Morgan Stanley
Ricky Goldwasser79%
$8 → $5.5MaintainsEqual-WeightGet Alert
09/14/2023Buy Now87.17%JP Morgan
Doug Anmuth86%
$6 → $7MaintainsNeutralGet Alert
08/11/2023Buy Now87.17%Goldman Sachs
Eric Sheridan79%
$6.25 → $7MaintainsNeutralGet Alert
08/10/2023Buy Now113.9%Deutsche Bank
George Hill61%
$6 → $8MaintainsHoldGet Alert
08/10/2023Buy Now167.38%Guggenheim
Sandy Draper73%
$8 → $10MaintainsBuyGet Alert
08/10/2023Buy Now60.43%JP Morgan
Doug Anmuth86%
$5 → $6MaintainsNeutralGet Alert
08/10/2023Buy Now194.12%Citigroup
Daniel Grosslight39%
$7 → $11MaintainsBuyGet Alert
08/10/2023Buy Now167.38%Evercore ISI Group
Mark Mahaney82%
$7 → $10MaintainsIn-LineGet Alert
08/10/2023Buy Now87.17%Goldman Sachs
Eric Sheridan79%
$6.25 → $7MaintainsNeutralGet Alert
08/10/2023Buy Now113.9%Credit Suisse
Jonathan Yong65%
$7 → $8MaintainsNeutralGet Alert
08/10/2023Buy Now113.9%RBC Capital
Sean Dodge46%
$6 → $8MaintainsSector PerformGet Alert
08/10/2023Buy Now154.01%DA Davidson
Robert Simmons54%
→ $9.5UpgradeNeutral → BuyGet Alert
08/10/2023Buy Now87.17%Wells Fargo
Stan Berenshteyn40%
$6 → $7MaintainsEqual-WeightGet Alert
07/31/2023Buy Now220.86%TD Cowen
Charles Rhyee36%
$6.5 → $12UpgradeMarket Perform → OutperformGet Alert
07/18/2023Buy Now87.17%Truist Securities
Jailendra Singh36%
$6 → $7MaintainsHoldGet Alert
07/17/2023Buy Now113.9%Morgan Stanley
Ricky Goldwasser79%
$6 → $8MaintainsEqual-WeightGet Alert
07/12/2023Buy Now—Keybanc
Scott Schoenhaus45%
—MaintainsSector WeightGet Alert
05/11/2023Buy Now113.9%B of A Securities
Michael Cherny78%
$9 → $8MaintainsBuyGet Alert
05/11/2023Buy Now60.43%RBC Capital
Sean Dodge46%
→ $6ReiteratesSector Perform → Sector PerformGet Alert
05/11/2023Buy Now67.11%Goldman Sachs
Eric Sheridan79%
$7 → $6.25MaintainsNeutralGet Alert
05/11/2023Buy Now87.17%Citigroup
Daniel Grosslight39%
$7.5 → $7MaintainsBuyGet Alert
03/08/2023Buy Now100.53%Citigroup
Daniel Grosslight39%
$7 → $7.5MaintainsBuyGet Alert
03/07/2023Buy Now113.9%Deutsche Bank
George Hill61%
$7 → $8MaintainsHoldGet Alert
03/02/2023Buy Now87.17%Goldman Sachs
Eric Sheridan79%
$8 → $7MaintainsNeutralGet Alert
03/02/2023Buy Now113.9%Credit Suisse
Jonathan Yong65%
$9 → $8MaintainsNeutralGet Alert
03/02/2023Buy Now60.43%Wells Fargo
Stan Berenshteyn40%
$5.5 → $6MaintainsEqual-WeightGet Alert
03/01/2023Buy Now87.17%Goldman Sachs
Eric Sheridan79%
$8 → $7MaintainsNeutralGet Alert
01/18/2023Buy Now113.9%Barclays
Steve Valiquette53%
$9 → $8MaintainsOverweightGet Alert
12/01/2022Buy Now87.17%Citigroup
Daniel Grosslight39%
→ $7Initiates → BuyGet Alert
11/09/2022Buy Now113.9%Goldman Sachs
Eric Sheridan79%
$10 → $8MaintainsNeutralGet Alert
11/09/2022Buy Now60.43%RBC Capital
Sean Dodge46%
$11 → $6MaintainsSector PerformGet Alert
11/09/2022Buy Now60.43%Morgan Stanley
Ricky Goldwasser79%
$10 → $6MaintainsEqual-WeightGet Alert
11/04/2022Buy Now113.9%JP Morgan
Doug Anmuth86%
$10 → $8UpgradeUnderweight → NeutralGet Alert
10/11/2022Buy Now140.64%Barclays
Ross Sandler70%
$13 → $9MaintainsOverweightGet Alert
09/16/2022Buy Now—Keybanc
Scott Schoenhaus45%
—Initiates → Sector WeightGet Alert
09/07/2022Buy Now73.8%Truist Securities
Jailendra Singh36%
→ $6.5Initiates → HoldGet Alert
08/12/2022Buy Now113.9%DA Davidson
Robert Simmons54%
→ $8Initiates → NeutralGet Alert
08/10/2022Buy Now167.38%Morgan Stanley
Ricky Goldwasser79%
$10.5 → $10MaintainsEqual-WeightGet Alert
08/09/2022Buy Now194.12%Credit Suisse
Jonathan Yong65%
$10 → $11MaintainsNeutralGet Alert
08/09/2022Buy Now167.38%Goldman Sachs
Eric Sheridan79%
$9 → $10MaintainsNeutralGet Alert
08/09/2022Buy Now194.12%RBC Capital
Sean Dodge46%
$6.5 → $11MaintainsSector PerformGet Alert
08/09/2022Buy Now247.59%Barclays
Steve Valiquette53%
$12 → $13MaintainsOverweightGet Alert
08/09/2022Buy Now194.12%SVB Leerink
Stephanie Davis41%
$8 → $11MaintainsMarket PerformGet Alert
07/20/2022Buy Now220.86%Barclays
Steve Valiquette53%
$15 → $12MaintainsOverweightGet Alert
07/18/2022Buy Now247.59%Guggenheim
Sandy Draper73%
$17 → $13MaintainsBuyGet Alert
06/23/2022Buy Now73.8%RBC Capital
Sean Dodge46%
$8 → $6.5MaintainsSector PerformGet Alert
06/22/2022Buy Now60.43%Baird
Vikram Kesavabhotla50%
$7 → $6MaintainsNeutralGet Alert
06/13/2022Buy Now140.64%Cowen & Co.
Charles Rhyee36%
$22 → $9MaintainsMarket PerformGet Alert
06/10/2022Buy Now140.64%Goldman Sachs
Eric Sheridan79%
$12 → $9DowngradeBuy → NeutralGet Alert
06/06/2022Buy Now194.12%B of A Securities
Michael Cherny78%
→ $11Reinstates → BuyGet Alert
06/01/2022Buy Now87.17%Baird
Vikram Kesavabhotla50%
$10 → $7DowngradeOutperform → NeutralGet Alert

FAQ

Q

What is the target price for GoodRx Holdings (GDRX) stock?

A

The latest price target for GoodRx Holdings (NASDAQ:GDRX) was reported by UBS on May 13, 2025. The analyst firm set a price target for $5.25 expecting GDRX to rise to within 12 months (a possible 40.37% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for GoodRx Holdings (GDRX)?

A

The latest analyst rating for GoodRx Holdings (NASDAQ:GDRX) was provided by UBS, and GoodRx Holdings maintained their neutral rating.

Q

When was the last upgrade for GoodRx Holdings (GDRX)?

A

The last upgrade for GoodRx Holdings Inc happened on May 23, 2024 when RBC Capital raised their price target to $10. RBC Capital previously had a sector perform for GoodRx Holdings Inc.

Q

When was the last downgrade for GoodRx Holdings (GDRX)?

A

The last downgrade for GoodRx Holdings Inc happened on January 2, 2024 when B of A Securities changed their price target from $8 to $4.5 for GoodRx Holdings Inc.

Q

When is the next analyst rating going to be posted or updated for GoodRx Holdings (GDRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GoodRx Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GoodRx Holdings was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.

Q

Is the Analyst Rating GoodRx Holdings (GDRX) correct?

A

While ratings are subjective and will change, the latest GoodRx Holdings (GDRX) rating was a maintained with a price target of $6.00 to $5.25. The current price GoodRx Holdings (GDRX) is trading at is $3.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch